Insider · CIK 0001302605

Nova Tina Susan

Reports to the SEC for 10 companies · EDMONTON

sec.gov

Transactions

Companies

Filings

CIK

0001302605

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	AUPHAurinia Pharmaceuticals Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+23.9K sh	—	—	23,931
2026-02-06	AZTAAzenta, Inc.A Award	Director	AAward	+5,663 sh	$27.85	+$158K	15,772
2025-06-10	XGNEXAGEN INC. · Stock Option(right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2025-05-16	AUPHAurinia Pharmaceuticals Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+63.7K sh	—	—	63,724
2025-02-07	AZTAAzenta, Inc.A Award	Director	AAward	+4,040 sh	$52.32	+$211K	10,109
2024-06-10	XGNEXAGEN INC. · Stock Option(right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2024-02-12	AZTAAzenta, Inc.A Award	Director	AAward	−2,465 sh	$65.93	−$163K	6,069
2023-06-15	XGNEXAGEN INC. · Stock Option(right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2023-02-13	AZTAAzenta, Inc.A Award	Director	AAward	+3,604 sh	—	—	3,604
2022-06-16	XGNEXAGEN INC. · Stock Option(right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,202 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Director	JOther	−3,067 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2022-03-11	ARENA PHARMACEUTICALS INCJ Other	Director	JOther	−17.8K sh	—	—	3,067
2022-03-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,800 sh	—	—	0
2022-03-03	VCYTVERACYTE, INC.A Award	President, CLIA U.S.	AAward	+56.5K sh	—	—	76,988
2022-03-03	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	President, CLIA U.S.	AAward	+103K sh	—	—	103,043
2022-03-02	VCYTVERACYTE, INC.F Tax Payment	President, CLIA U.S.	FTax Payment	−10.7K sh	$27.84	−$298K	20,442
2021-06-17	XGNEXAGEN INC. · Stock Option(right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2021-06-11	ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+7,202 sh	—	—	7,202
2021-06-11	ARENA PHARMACEUTICALS INCA Award	Director	AAward	+3,067 sh	—	—	19,643
2020-08-26	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+1,200 sh	$14.90	+$17.9K	17,776
2020-08-26	ARENA PHARMACEUTICALS INCStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,200 sh	—	—	0
2020-08-26	ARENA PHARMACEUTICALS INCStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.5K sh	—	—	0
2020-08-26	ARENA PHARMACEUTICALS INCStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,600 sh	—	—	0
2020-08-26	ARENA PHARMACEUTICALS INCS Sale	Director	SSale	−17.3K sh	$67.94	−$1.18M	16,576
2020-08-26	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+12.5K sh	$20.00	+$250K	33,876
2020-08-26	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+3,600 sh	$12.70	+$45.7K	21,376
2020-06-18	XGNEXAGEN INC. · Stock Option(right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2020-06-12	ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2020-06-12	ARENA PHARMACEUTICALS INCA Award	Director	AAward	+2,446 sh	—	—	16,576
2020-06-08	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	President, CLIA U.S.	AAward	+10K sh	—	—	10,000
2019-09-18	XGNEXAGEN INC. · Stock Option (right to buy)A Award	Director	AAward	+13.6K sh	—	—	13,613
2019-09-02	CFORCapForce Inc.A Award	Director	AAward	+750 sh	—	—	750
2019-06-13	ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2019-06-13	ARENA PHARMACEUTICALS INCA Award	Director	AAward	+2,654 sh	—	—	14,130
2019-06-12	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	President, CLIA U.S.	AAward	+10K sh	—	—	10,000
2019-03-07	ARENA PHARMACEUTICALS INCStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,200 sh	—	—	0
2019-03-07	ARENA PHARMACEUTICALS INCS Sale	Director	SSale	−1,200 sh	$45.99	−$55.2K	11,476
2019-03-07	ARENA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+1,200 sh	$40.10	+$48.1K	12,676
2018-06-13	CFORCapForce Inc. · Stock OptionA Award	Director	AAward	+2,500 sh	—	—	2,500
2018-06-13	ARENA PHARMACEUTICALS INCStock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2018-06-13	ARENA PHARMACEUTICALS INCA Award	Director	AAward	+3,050 sh	—	—	11,476
2018-06-07	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	President, CLIA U.S.	AAward	+10K sh	—	—	10,000
2017-06-13	ARENA PHARMACEUTICALS INCEmployee Stock Option (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000
2017-06-08	CFORCapForce Inc. · Stock OptionA Award	Director	AAward	+12.5K sh	—	—	12,500
2017-06-07	VCYTVERACYTE, INC. · Stock Option (right to buy)A Award	President, CLIA U.S.	AAward	+10K sh	—	—	10,000

Recent filings

Accepted (ET)
Jun 84
Nova Tina Susan0001302605-26-000002
SEC(opens sec.gov)
Feb 64
Nova Tina Susan0001193125-26-041527
SEC(opens sec.gov)
Jun 124
Nova Tina Susan0001274737-25-000038
SEC(opens sec.gov)
May 164
Nova Tina Susan0001600620-25-000078
SEC(opens sec.gov)
Feb 114
Nova Tina Susan0000950170-25-017893
SEC(opens sec.gov)
Jun 124
Nova Tina Susan0001274737-24-000061
SEC(opens sec.gov)
Feb 134
Nova Tina Susan0000950170-24-014558
SEC(opens sec.gov)
Jun 204
Nova Tina Susan0001274737-23-000069
SEC(opens sec.gov)
Feb 154
Nova Tina Susan0001209191-23-009725
SEC(opens sec.gov)
Jun 214
Nova Tina Susan0001274737-22-000044
SEC(opens sec.gov)
Mar 114
Nova Tina Susan0001628280-22-005918
SEC(opens sec.gov)
Mar 74
Nova Tina Susan0001384101-22-000052
SEC(opens sec.gov)

Companies

Address

#140, 14315-118 AVENUE

EDMONTON, T5L 4S6